Bronchial challenges and respiratory symptoms in elite swimmers and winter sport athletes: Airway hyperresponsiveness in asthma: Its measurement and clinical significance

Chest

Volumn 138, Issue 2 SUPPL., 2010, Pages 31S-37S

  Bougault, Valérie ^a,b   Turmel, Julie ^a   Boulet, Louis Philippe ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIV LILLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; FORMOTEROL; HISTAMINE; METHACHOLINE; BRONCHOCONSTRICTING AGENT; METHACHOLINE CHLORIDE;

ADULT; ARTICLE; ASTHMA; ATHLETE; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CALCULATION; CHEST TIGHTNESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; EUCAPNIC VOLUNTARY HYPERPNEA; EXERCISE; EXERCISE INDUCED BRONCHOCONSTRICTION; EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; HUMAN EXPERIMENT; HYPERPNEA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SPIROMETRY; SPUTUM; SWIMMING; WHEEZING; WINTER SPORT; ADOLESCENT; ASTHMA, EXERCISE-INDUCED; BRONCHOCONSTRICTION; CANADA; COMPARATIVE STUDY; DIAGNOSTIC USE; FEMALE; INHALATION TEST; INHALATIONAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; YOUNG ADULT;

ADMINISTRATION, INHALATION; ADOLESCENT; ASTHMA, EXERCISE-INDUCED; ATHLETES; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOCONSTRICTION; BRONCHOCONSTRICTOR AGENTS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; METHACHOLINE CHLORIDE; PREVALENCE; QUEBEC; RISK FACTORS; SWIMMING; YOUNG ADULT;

EID: 77956853364     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-1689     Document Type: Article

References (24)

1. Fitch KD, Sue-Chu M, Anderson SD et al. Asthma and the elite athlete: summary of the International Olympic Committee's consensus conference, Lausanne, Switzerland, January 22-24, 2008. J Allergy Clin Immunol. 2008;122(2):254-260.
2. Anderson SD, Sue-Chu M, Perry CP, et al. Bronchial challenges in athletes applying to inhale a beta2-agonist at the 2004 Summer Olympics. J Allergy Clin Immunol. 2006;117(4):767-773.
3. Capão-Filipe M, Moreira A, Delgado L, Rodrigues J, Vaz M. Exercise-induced bronchoconstriction and respiratory symptoms in elite athletes. Allergy. 2003;58(11):1196. (Pubitemid 37372309)
4. Rundell KW, Im J, Mayers LB, Wilber RL, Szmedra L, Schmitz HR. Self-reported symptoms and exercise-induced asthma in the elite athlete. Med Sci Sports Exerc. 2001;33(2):208-213.
5. International Olympic Committee. IOC: Beta2-adrenoceptor agonists and Olympic Games in Beijing. http://multimedia.olympic.org/pdf/en-report-1302.pdf. Accessed April 11, 2010.
6. World Anti-Doping Agency (WADA). Asthma - medical information to support the decisions of TUECs. http://www.wada-ama.org/Documents/Science-Medicine/ Medical-info-to-support-TUECs/WADA-Medical-info-Asthma-v2.3-EN.pdf. Accessed April 11, 2010.
7. Crapo RO, Casaburi R, Coates AL, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med. 2000;161(1):309-329.
8. Malo JL, Pineau L, Cartier A, Martin RR. Reference values of the provocative concentrations of methacholine that cause 6% and 20% changes in forced expiratory volume in one second in a normal population. Am Rev Respir Dis. 1983;128(1):8-11.
9. Miller MR, Crapo R, Hankinson J, et al; ATS/ERS Task Force. General considerations for lung function testing. Eur Respir J. 2005;26(1):153-161.
10. Knudson RJ, Lebowitz MD, Holberg CJ, Burrows B. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis. 1983;127(6):725-734. (Pubitemid 13101554)
11. Anderson SD, Brannan JD. Methods for "indirect" challenge tests including exercise, eucapnic voluntary hyperpnea, and hypertonic aerosols. Clin Rev Allergy Immunol. 2003;24(1):27-54.
12. Hurwitz KM, Argyros GJ, Roach JM, Eliasson AH, Phillips YY. Interpretation of eucapnic voluntary hyperventilation in the diagnosis of asthma. Chest. 1995;108(5):1240-1245.
13. Juniper EF. CDHF. Histamine and Methacholine Inhalation Test: a Laboratory Tidal Breathing Method. Lund, Sweden: Astra Draco AB; 1994: 33-34.
14. Turcotte H, Langdeau JB, Thibault G, Boulet LP. Prevalence of respiratory symptoms in an athlete population. Respir Med. 2003;97(8):955-963.
15. Langdeau JB, Turcotte H, Bowie DM, Jobin J, Desgagné P, Boulet LP. Airway hyperresponsiveness in elite athletes. Am J Respir Crit Care Med. 2000;161(5):1479-1484.
16. Potts JE. Adverse Respiratory Health Effects Of Competitive Swimming: The Prevalence of Symptoms, Illness, and Bronchial Responsiveness to Methacholine and Exercise. Vancouver, BC, Canada: The University of British Columbia; 1994:1-226.
17. Castricum A, Holzer K, Brukner P, Irving L. The role of the bronchial provocation challenge tests in the diagnosis of exercise induced bronchoconstriction in elite swimmers. Br J Sports Med. In press.
18. Pedersen L, Winther S, Backer V, Anderson SD, Larsen KR. Airway responses to eucapnic hyperpnea, exercise, and methacholine in elite swimmers. Med Sci Sports Exerc. 2008;40(9):1567-1572.
19. Inbar O, Dotan R, Dlin RA, Neuman I, Bar-Or O. Breathing dry or humid air and exercise-induced asthma during swimming. Eur J Appl Physiol Occup Physiol. 1980;44(1):43-50. (Pubitemid 10066789)
20. Donnelly PM. Exercise induced asthma: the protective role of CO2 during swimming. Lancet. 1991;337(8734):179-180.
21. Bougault V, Turmel J, St-Laurent J, Bertrand M, Boulet LP. Asthma, airway inflammation and epithelial damage in swimmers and cold-air athletes. Eur Respir J. 2009;33(4):740-746.
22. 1. Chest. 2000;117(3):881-883.
23. Koskela HO. Cold air-provoked respiratory symptoms: the mechanisms and management. Int J Circumpolar Health. 2007;66(2):91-100.
24. Coleridge HM, Coleridge JC, Ginzel KH, Baker DG, Banzett RB, Morrison MA. Stimulation of 'irritant' receptors and afferent C-fibres in the lungs by prostaglandins. Nature. 1976;264(5585):451-453.